Skip to main content
USDW
OTC Technology

MADE IN USA INC. Announces Non-Binding Strategic Partnership with Rosalind, Inc. to Enter Healthcare Data Market

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Technology
Sentiment info
Positive
Importance info
7
Price
$0.13
Mkt Cap
0
52W Low
$0.033
52W High
$0.033
52W Position info
300% above low
Off High info
at 52W high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

USDW has more than doubled off its 52-week low of $0.033 on light trading volume (0.3× avg).

Summary

MADE IN USA INC. has signed a non-binding term sheet with Rosalind, Inc. to form a new entity, Rosalind Systems, Inc., aiming to expand its data wallet technology into the healthcare and life sciences sector.


Key Events · M&A and Partnerships · USDW

  • Strategic Partnership Announced

    MADE IN USA INC. executed a non-binding term sheet with Rosalind, Inc. to form Rosalind Systems, Inc., a new operating entity.

  • Entry into Healthcare Data Market

    The new entity will integrate USDW's data wallet and certification technologies with Rosalind's platform to expand into healthcare, life sciences, and data infrastructure.

  • Framework for Capital Formation

    The proposed structure is designed to support capital formation and expansion into areas including biopharma, clinical data, and public health infrastructure.

  • Non-Binding Agreement

    The term sheet is non-binding and subject to the negotiation and execution of definitive agreements, completion of financing, and satisfaction of other customary closing conditions.


Analysis · USDW · Technology

This strategic initiative is significant for MADE IN USA INC., especially given its previously disclosed "going concern" issues and zero cash. The proposed partnership with Rosalind, Inc. to create Rosalind Systems, Inc. outlines a potential path for growth and capital formation in the critical healthcare data sector. While the term sheet is non-binding and subject to definitive agreements and financing, it signals a strategic direction and potential for future revenue streams and investment, which is crucial for the company's long-term viability. The focus on verifiable, trusted data in healthcare aligns with current market needs.

At the time of this filing, USDW was trading at $0.13 on OTC in the Technology sector. The 52-week trading range was $0.03 to $0.03. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

USDW - Latest Insights

USDW
Jul 09, 2026, 2:17 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $5.00
Real-time Price: $5.00 info
Change: $0 (0%) info
Market Cap: N/A info
USDW
Jun 29, 2026, 10:59 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.130
Real-time Price: $5.00 info
Change: +$4.87 (+3,746%) info
Market Cap: N/A info
USDW
Jun 24, 2026, 9:32 AM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
Price at Filing: $0.130
Real-time Price: $5.00 info
Change: +$4.87 (+3,746%) info
Market Cap: N/A info
USDW
Jun 22, 2026, 5:05 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.130
Real-time Price: $5.00 info
Change: +$4.87 (+3,746%) info
Market Cap: N/A info
USDW
Jun 22, 2026, 4:58 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.130
Real-time Price: $5.00 info
Change: +$4.87 (+3,746%) info
Market Cap: N/A info